Psoas Muscle Cross-Sectional Area and Outcomes Following Colorectal Cancer Surgery

Main Article Content

Matthew Mouat
Ashok Gunawardene
Lisa Sweetman
Elizabeth Dennett
Peter Larsen

Abstract

Background: Frailty and functional status are established risk factors for postoperative morbidity
and mortality, but new data also suggest a link between sarcopenia and longer-term oncological
outcomes in colorectal cancer. Cross-sectional imaging is performed routinely prior to elective
resection and provides a means to measure psoas muscle cross-sectional area, which in turn is a
surrogate marker of sarcopenia.
Methods: A retrospective cohort study of patients undergoing elective surgery with curative intent
for colorectal cancer. Using automated software, psoas muscle cross-sectional area was measured
and the relationship with five-year disease-free survival was evaluated using Kaplan-Meier survival
curves.
Results: A significant relationship was found among patients with a low (below median) psoas
muscle cross-sectional area, HR 1.57 (95% CI 1.1-2.5) p=0.04.
Conclusion: This study demonstrated a potential relationship between psoas muscle crosssectional area and disease-free survival, highlighting the further utility of pre-operative staging
CT in predicting prognosis in patients with colorectal cancer.

Downloads

Download data is not yet available.

Article Details

How to Cite
Mouat, M., Gunawardene, A., Sweetman, L., Dennett, E., & Larsen, P. (2022). Psoas Muscle Cross-Sectional Area and Outcomes Following Colorectal Cancer Surgery. British Journal Of Surgical Science, 2(2). https://doi.org/10.54323/bjoss.2022.13
Section
LOWER GI SURGERY

References

REFERENCES:

Robinson TN, Wu DS, Pointer L, Dunn CL, Cleveland JC, Moss M. Simple frailty score predicts postoperative complications across surgical specialties. Am J Surg. 2013; 206(4): 544-550.

Fagard K, Leonard S, Deschodt M et al. The impact of frailty on postoperative outcomes in individuals aged 65 and over undergoing elective surgery for colorectal cancer: A systematic review. Journal of Geriatric Oncology 2016; 7(6): 479–491.

Makary MA, Segev DL, Pronovost PJ et al. Frailty as a Predictor of Surgical Outcomes in Older Patients. Journal of the American College of Surgeons 2010; 210(6): 901–908.

Garg L, Agrawal S, Pew T et al. Psoas Muscle Area as a Predictor of Outcomes in Transcatheter Aortic Valve Implantation. The American Journal of Cardiology 2017; 119(3), 457–460.

Clegg A, Young J, Iliffe S, Rikkert MO, Rockwood K. Frailty in elderly people. The Lancet 2013; 381(9868): 752–762.

Lieffers JR, Bathe OF, Fassbender K, Winget M, Baracos VE. Sarcopenia is associated with postoperative infection and delayed recovery from colorectal cancer resection surgery. British Journal of Cancer 2012; 107(6): 931–936.

Peng PD, van Vledder MG, Tsai S et al. Sarcopenia negatively impacts short-term outcomes in patients undergoing hepatic resection for colorectal liver metastasis. HPB 2011; 13(7): 439–446.

Boutin RD, Yao L, Canter RJ, Lenchik L. Sarcopenia: Current Concepts and Imaging Implications. American Journal of Roentgenology 2015; 205(3): W255–W266.

Jones KI, Doleman B, Scott S, Lund JN, Williams JP. Simple psoas cross-sectional area measurement is a quick and easy method to assess sarcopenia and predicts major surgical complications. Colorectal Disease 2015; 17(1): O20–O26.

Miller AL, Englesbe MJ, Diehl KM et al. Preoperative Psoas Muscle Size Predicts Postoperative Delirium in Older Adults Undergoing Surgery: A Pilot Cohort Study. Journal of the American Geriatrics Society 2017; 65(1): e23–e24.

Reisinger KW, A van Vugt JL, W Tegels JJ et al. Functional Compromise Reflected by Sarcopenia, Frailty, and Nutritional Depletion Predicts Adverse Postoperative Outcome After Colorectal Cancer Surgery. Ann Surg 2015 Feb; 261(2): 345-52.

McClellan T, Allen BC, Kappus M et al. Repeatability of Computerized Tomography–Based Anthropomorphic Measurements of Frailty in Patients With Pulmonary Fibrosis Undergoing Lung Transplantation. Current Problems in Diagnostic Radiology 2017; 46(4): 300–304.

New Zealand Guidelines Group. Guidance on surveillance for people at increased risk of colorectal cancer [PDF on Internet]. Wellington: New Zealand Guidelines Group [Updated 2011]. Available from: https://www.health.govt.nz/system/files/documents/publications/colorectal-cancer-surveillance-guidance.pdf

Birgisson H, Wallin U, Holmberg L, Glimelius B. Survival endpoints in colorectal cancer and the effect of second primary other cancer on disease free survival. BMC cancer. 2011; 11(1): 438.

Prado CMM, Lieffers JR, McCargar LJ et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. The Lancet. Oncology 2008; 9(7): 629–635.

Fearon K, Strasser F, Anker SD et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 2011; 12(5): 489-95.

Park SY, Yoon JK, Lee SJ, Haam S, Jung J. Prognostic value of preoperative total psoas muscle area on long-term outcome in surgically treated oesophageal cancer patients. Interact Cardiovasc Thorac Surg. 2017; 24(1): 13-9.

Hanaoka M, Yasuno M, Ishiguro M et al. Morphologic change of the psoas muscle as a surrogate marker of sarcopenia and predictor of complications after colorectal cancer surgery. Int J Colorectal Dis. 2017; 32(6): 847-56.